{"id":"ciprofibrate","rwe":[{"pmid":"41138152","year":"2025","title":"Visible-Light-Induced Monofluoromethylation of Styrenes.","finding":"","journal":"Organic letters","studyType":"Clinical Study"},{"pmid":"40959986","year":"2025","title":"Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers.","finding":"","journal":"Journal of medicinal chemistry","studyType":"Clinical Study"},{"pmid":"40898978","year":"2025","title":"Developmental Patterns of Hepatic Peroxisome Proliferator-Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax.","finding":"","journal":"Journal of experimental zoology. Part A, Ecological and integrative physiology","studyType":"Clinical Study"},{"pmid":"39216539","year":"2024","title":"A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate.","finding":"","journal":"Journal of pharmaceutical sciences","studyType":"Clinical Study"},{"pmid":"38268925","year":"2023","title":"Identification and validation of platelet-related diagnostic markers and potential drug screening in ischemic stroke by integrating comprehensive bioinformatics analysis and machine learning.","finding":"","journal":"Frontiers in immunology","studyType":"Clinical Study"}],"tags":[{"label":"ciprofibrate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Peroxisome proliferator-activated receptor alpha","category":"target"},{"label":"PPARA","category":"gene"},{"label":"C10AB08","category":"atc"},{"label":"Active","category":"status"},{"label":"Hypertriglyceridemia","category":"indication"},{"label":"Mixed hyperlipidemia","category":"indication"},{"label":"Winthrop Pharmaceuticals UK Limited","category":"company"},{"label":"Antimetabolites","category":"pharmacology"},{"label":"Carcinogens","category":"pharmacology"},{"label":"Hypolipidemic Agents","category":"pharmacology"},{"label":"Lipid Regulating Agents","category":"pharmacology"},{"label":"Noxae","category":"pharmacology"},{"label":"Peroxisome Proliferators","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":30.697,"date":"","count":6,"signal":"Tonic clonic movements","source":"DrugCentral FAERS","actionTaken":"Reported 6 times (LLR=31)"},{"llr":30.616,"date":"","count":6,"signal":"Haematoma muscle","source":"DrugCentral FAERS","actionTaken":"Reported 6 times (LLR=31)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Winthrop Pharmaceuticals UK Limited","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CIPROFIBRATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:13:48.964224+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:13:56.335437+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CIPROFIBRATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:13:57.713343+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Peroxisome proliferator-activated receptor alpha agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:13:58.295607+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL557555/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:13:58.183218+00:00"}},"allNames":"lipanor","offLabel":[],"synonyms":["ciprofibrate","lipanor","oroxadin"],"timeline":[{"date":"2009-06-18","type":"positive","source":"DrugCentral","milestone":"UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval (Winthrop Pharmaceuticals UK Limited)"}],"approvals":[{"date":"2009-06-18","orphan":false,"company":"Winthrop Pharmaceuticals UK Limited","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)"}],"brandName":"Lipanor","ecosystem":[{"indication":"Hypertriglyceridemia","otherDrugs":[{"name":"atorvastatin","slug":"atorvastatin","company":"Pfizer"},{"name":"choline fenofibrate","slug":"choline-fenofibrate","company":"Abbvie"},{"name":"fenofibrate","slug":"fenofibrate","company":"Abbvie"},{"name":"gemfibrozil","slug":"gemfibrozil","company":"Pfizer Pharms"}],"globalPrevalence":1680000000},{"indication":"Mixed hyperlipidemia","otherDrugs":[{"name":"atorvastatin","slug":"atorvastatin","company":"Pfizer"},{"name":"cerivastatin","slug":"cerivastatin","company":"Bayer Pharms"},{"name":"choline fenofibrate","slug":"choline-fenofibrate","company":"Abbvie"},{"name":"ezetimibe","slug":"ezetimibe","company":"Msd Intl Gmbh"}],"globalPrevalence":390000000}],"mechanism":{"target":"Peroxisome proliferator-activated receptor alpha","targets":[{"gene":"PPARA","source":"DrugCentral","target":"Peroxisome proliferator-activated receptor alpha","protein":"Peroxisome proliferator-activated receptor alpha"}],"modality":"Small Molecule","drugClass":"ciprofibrate","explanation":"","oneSentence":"","technicalDetail":"Lipanor acts as a PPAR-alpha agonist, binding to the receptor and activating its transcriptional activity, leading to increased expression of genes involved in fatty acid oxidation and decreased expression of genes involved in lipogenesis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/658","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CIPROFIBRATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CIPROFIBRATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:02:52.577307","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:14:00.126086+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"clofibrate","drugSlug":"clofibrate","fdaApproval":"1967-02-08","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"gemfibrozil","drugSlug":"gemfibrozil","fdaApproval":"1981-12-21","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fenofibrate","drugSlug":"fenofibrate","fdaApproval":"1993-12-31","patentExpiry":"May 31, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"choline fenofibrate","drugSlug":"choline-fenofibrate","fdaApproval":"2008-12-15","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"ciprofibrate","indications":{"approved":[{"name":"Hypertriglyceridemia","source":"DrugCentral","snomedId":302870006,"regulator":"FDA","usPrevalence":null,"globalPrevalence":1680000000,"prevalenceMethod":"curated","prevalenceSource":"J Health Popul Nutr, 2025 (PMID:40859400)"},{"name":"Mixed hyperlipidemia","source":"DrugCentral","snomedId":267434003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":390000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"clofibrate","brandName":"clofibrate","genericName":"clofibrate","approvalYear":"1967","relationship":"same-class"},{"drugId":"gemfibrozil","brandName":"gemfibrozil","genericName":"gemfibrozil","approvalYear":"1981","relationship":"same-class"},{"drugId":"fenofibrate","brandName":"fenofibrate","genericName":"fenofibrate","approvalYear":"1993","relationship":"same-class"},{"drugId":"choline-fenofibrate","brandName":"choline fenofibrate","genericName":"choline fenofibrate","approvalYear":"2008","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06858332","phase":"","title":"Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-15","conditions":["Atherosclerotic Cardiovascular Disease"],"enrollment":2382,"completionDate":"2027-09-30"},{"nctId":"NCT03662984","phase":"PHASE3","title":"Ciprofibrate and Pre-diabetes","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2018-11-01","conditions":["Myocardial Insulin Sensitivity","Impaired Glucose Metabolism","Diastolic Dysfunction"],"enrollment":11,"completionDate":"2020-11-13"},{"nctId":"NCT01480687","phase":"PHASE4","title":"Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia","status":"UNKNOWN","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2011-05","conditions":["Hypertension","Hypertriglyceridemia"],"enrollment":52,"completionDate":"2012-12"},{"nctId":"NCT00350038","phase":"PHASE4","title":"Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-02","conditions":["Hypertension","Dyslipidemia"],"enrollment":60,"completionDate":"2007-08"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004087","UNII":"F8252JGO9S","CHEBI":"CHEBI:50867","INN_ID":"4057","RXNORM":"21149","UMLSCUI":"C0055775","chemblId":"CHEMBL557555","ChEMBL_ID":"CHEMBL557555","KEGG_DRUG":"D03521","DRUGBANK_ID":"DB09064","PUBCHEM_CID":"2763","SNOMEDCT_US":"320016006","IUPHAR_LIGAND_ID":"3438","MESH_SUPPLEMENTAL_RECORD_UI":"C019304"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Winthrop Pharmaceuticals UK Limited","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"99%"},"publicationCount":499,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"C10AB08","allCodes":["C10AB08"]},"biosimilarFilings":[],"originalDeveloper":"Winthrop Pharmaceuticals UK Limited","recentPublications":[{"date":"2025 Nov 7","pmid":"41138152","title":"Visible-Light-Induced Monofluoromethylation of Styrenes.","journal":"Organic letters"},{"date":"2025 Oct 9","pmid":"40959986","title":"Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers.","journal":"Journal of medicinal chemistry"},{"date":"2025 Dec","pmid":"40898978","title":"Developmental Patterns of Hepatic Peroxisome Proliferator-Activated Receptor (PPAR) Expression in Xenopus laevis and Response to Pharmaceutical Agonists During Metamorphic Climax.","journal":"Journal of experimental zoology. Part A, Ecological and integrative physiology"},{"date":"2024 Nov","pmid":"39216539","title":"A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate.","journal":"Journal of pharmaceutical sciences"},{"date":"2023","pmid":"38268925","title":"Identification and validation of platelet-related diagnostic markers and potential drug screening in ischemic stroke by integrating comprehensive bioinformatics analysis and machine learning.","journal":"Frontiers in immunology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Winthrop Pharmaceuticals UK Limited","companyId":"winthrop-pharmaceuticals-uk-limited","modality":"Small molecule","firstApprovalDate":"1985","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)","status":"approved","approval_date":"2009-06-18T00:00:00.000Z","mah":"Winthrop Pharmaceuticals UK Limited","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:14:00.126086+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}